NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

CRISPR及Cas遺傳基因的市場規模,佔有率,趨勢分析報告:產品、各服務,各用途,各最終用途,各地區,各市場區隔預測(2020∼2027年)

CRISPR & Cas Genes Market Size, Share & Trends Analysis Report, By Product & Service ; By Application; By End Use; and By Region; Segment Forecasts, 2020 - 2027

出版商 Polaris Market Research 商品編碼 977353
出版日期 內容資訊 英文 132 Pages
商品交期: 最快1-2個工作天內
價格
CRISPR及Cas遺傳基因的市場規模,佔有率,趨勢分析報告:產品、各服務,各用途,各最終用途,各地區,各市場區隔預測(2020∼2027年) CRISPR & Cas Genes Market Size, Share & Trends Analysis Report, By Product & Service ; By Application; By End Use; and By Region; Segment Forecasts, 2020 - 2027
出版日期: 2020年12月01日內容資訊: 英文 132 Pages
簡介

全球CRISPR及Cas遺傳基因的市場規模預計至2027年達到47億5千萬美元。本報告提供目前市場趨勢的詳細的洞察,關於未來市場成長的預測分析。

支撐CRISPR及CRISPR相關(Cas)遺傳基因市場成長的主要原因,有遺傳基因編輯平台的技術進步,和預期提高CRISPR技術的整體準確度的各種抗CRISPR蛋白質的上市等。

本報告提供CRISPR及Cas遺傳基因市場相關調查,市場概要,以及產品、各服務,各用途,各最終用途,各地區的趨勢,及加入此市場的主要企業的簡介等。

目錄

第1章 簡介

  • 報告的說明
    • 調查的目的
    • 市場範圍
    • 假設
  • 利害關係者

第2章 摘要整理

  • 市場概況

第3章 調查手法

  • 概要
    • 資料探勘
  • 資料來源
    • 一級資訊來源
    • 第二手資料

第4章 CRISPR及Cas遺傳基因市場洞察

  • CRISPR及Cas遺傳基因-產業的概述
  • CRISPR及Cas遺傳基因 市場動態
    • 推動要素和機會
    • 阻礙因素與課題
  • 波特的五力分析
    • 供給企業談判力(中度)
    • 新加入廠商的威脅:(低)
    • 買方議價能力(中度)
    • 替代威脅(中度)
    • 現有企業間的競爭(高)
  • 大環境分析
  • CRISPR及Cas遺傳基因Market產業趨勢

第5章 全球CRISPR及Cas遺傳基因市場,各產品、服務

  • 主要調查結果
  • 簡介
    • 全球CRISPR及Cas遺傳基因市場,各產品及服務,2016年∼2027年(百萬美元)
  • 產品
    • 全球CRISPR及Cas遺傳基因市場,產品,各地區,2016年∼2027年(百萬美元)
    • 套件和酵素
    • 程式庫
    • 設計工具
    • 抗體
    • 其他
  • 服務
    • 全球CRISPR及Cas遺傳基因市場,服務,各地區,2016年∼2027年(百萬美元)
    • 細胞株工程
    • gRNA設計
    • 微生物遺傳基因編輯
    • DNA合成

第6章 全球CRISPR及Cas遺傳基因市場,各用途

  • 主要調查結果
  • 簡介
    • 全球CRISPR及Cas遺傳基因市場,各用途,2016年∼2027年(百萬美元)
  • 生物醫學
    • 全球CRISPR及Cas遺傳基因市場,生物化學,各地區,2016年∼2027年(百萬美元)
  • 農業
    • 全球CRISPR及Cas遺傳基因市場,農業,各地區,2016年∼2027年(百萬美元)

第7章 全球CRISPR及Cas遺傳基因市場,各最終用途

  • 主要調查結果
  • 簡介
    • 全球CRISPR及Cas遺傳基因市場,各最終用途,2016年∼2027年(百萬美元)
  • 生物科技及製藥企業
    • 全球CRISPR及Cas遺傳基因市場,生物科技及製藥公司,各地區,2016年∼2027年(百萬美元)
  • 學者及政府調查機關
    • 全球CRISPR及Cas遺傳基因市場,學術機構、政府調查機關,各地區,2016年∼2027年(百萬美元)
  • 委託調查機關(CRO)
    • 全球CRISPR及Cas遺傳基因市場,委託調查機關(CRO),各地區,2016年∼2027年(百萬美元)

第8章 全球CRISPR及Cas遺傳基因市場,各地區

  • 主要調查結果
  • 簡介
    • 全球CRISPR及Cas遺傳基因市場,地區,2016年∼2027年(百萬美元)
  • CRISPR及Cas遺傳基因市場-北美
    • 北美:CRISPR及Cas遺傳基因市場,各產品及服務,2016年∼2027年(百萬美元)
    • 北美:CRISPR及Cas遺傳基因市場,各用途,2016年∼2027年(百萬美元)
    • 北美:CRISPR及Cas遺傳基因市場,各最終用途,2016年∼2027年(百萬美元)
    • CRISPR及Cas遺傳基因市場-美國
    • CRISPR及Cas遺傳基因Market-加拿大
  • CRISPR及Cas遺傳基因Market-歐洲
    • 歐洲:CRISPR及Cas遺傳基因市場,各產品及服務,2016年∼2027年(百萬美元)
    • 歐洲:CRISPR及Cas遺傳基因市場,各用途,2016年∼2027年(百萬美元)
    • 歐洲:CRISPR及Cas遺傳基因市場,各最終用途,2016年∼2027年(百萬美元)
    • CRISPR及Cas遺傳基因Market-英國
    • CRISPR及Cas遺傳基因Market-法國
    • CRISPR及Cas遺傳基因Market-德國
    • CRISPR及Cas遺傳基因Market-義大利
    • CRISPR及Cas遺傳基因Market-西班牙
    • CRISPR及Cas遺傳基因Market-荷蘭
    • CRISPR及Cas遺傳基因Market-奧地利
  • CRISPR及Cas遺傳基因Market-亞太地區
    • 亞太地區:CRISPR及Cas遺傳基因市場,各產品及服務,2016年∼2027年(百萬美元)
    • 亞太地區:CRISPR及Cas遺傳基因市場,各用途,2016年∼2027年(百萬美元)
    • 亞太地區:CRISPR及Cas遺傳基因市場,各最終用途,2016年∼2027年(百萬美元)
    • CRISPR及Cas遺傳基因Market-中國
    • CRISPR及Cas遺傳基因Market-印度
    • CRISPR及Cas遺傳基因Market-馬來西亞
    • CRISPR及Cas遺傳基因Market-日本
    • CRISPR及Cas遺傳基因Market-印尼
    • CRISPR及Cas遺傳基因Market-韓國
  • CRISPR及Cas遺傳基因Market-中東及非洲
    • 中東、非洲:CRISPR及Cas遺傳基因市場,各產品及服務,2016年∼2027年(百萬美元)
    • 中東、非洲:CRISPR及Cas遺傳基因市場,各用途,2016年∼2027年(百萬美元)
    • 中東、非洲:CRISPR及Cas遺傳基因市場,各最終用途,2016年∼2027年(百萬美元)
    • CRISPR及Cas遺傳基因Market-沙烏地阿拉伯
    • CRISPR及Cas遺傳基因 Market-UAE
    • CRISPR及Cas遺傳基因Market-以色列
    • CRISPR及Cas遺傳基因Market-南非
  • CRISPR及Cas遺傳基因Market-南美
    • 南美:CRISPR及Cas遺傳基因市場,各產品及服務,2016年∼2027年(百萬美元)
    • 南美。:CRISPR及Cas遺傳基因市場,各用途,2016年∼2027年(百萬美元)
    • 南美:CRISPR及Cas遺傳基因市場,各最終用途,2016年∼2027年(百萬美元)
    • CRISPR及Cas遺傳基因Market-墨西哥
    • CRISPR及Cas遺傳基因Market-巴西
    • CRISPR及Cas遺傳基因Market-阿根廷

第9章 競爭情形

  • 擴張和收購的分析
    • 擴張
    • 收購
  • 產品銷售
  • 夥伴關係/合作/契約/展示會

第10章 企業簡介

  • Addgene
  • AstraZeneca
  • Caribou Biosciences, Inc.
  • Cellectis
  • CRISPR Therapeutics
  • Danaher Corporation
  • Editas Medicine, Inc.
  • Horizon Discovery Group Plc
  • Mammoth Biosciences
  • New England BioLabs
目錄
Product Code: PM1738

Title:
CRISPR & Cas Genes Market Size, Share & Trends Analysis Report, By Product & Service (Product {Kits & Enzymes, Libraries, Design Tool, Antibodies, and Others}, and Service {Cell Line Engineering, gRNA Design, Microbial Gene Editing, and DNA synthesis); By Application; By End Use; and By Region; Segment Forecasts, 2020 - 2027.

The global CRISPR & Cas Genes market size is expected to reach USD 4.75 billion by 2027 according to a new study by Polaris Market Research. The report "CRISPR & Cas Genes Market Size, Share & Trends Analysis Report, By Product & Service (Product {Kits & Enzymes, Libraries, Design Tool, Antibodies, and Others}, and Service {Cell Line Engineering, gRNA Design, Microbial Gene Editing, and DNA synthesis); By Application (Biomedical and Agricultural), and By End Use (Biotechnology & Pharmaceutical Companies, Academics & Government Research Institutes, and Contract Research Organizations (CROs)), and Segment Forecasts, 2020 - 2027" gives a detailed insight into current market dynamics and provides analysis on future market growth.

CRISPR refers to a gene editing tool through which the biological researchers and scientists can modify the genomes of various living creatures. The CRISPR technique relies on the antiviral defense mechanism of the bacteria-based CRISPR-Cas9 system. The synthetically created guide RNA is being complexed with Cas9 nuclease and delivered into the cell. Through this technique, the genome of cells can be sliced at any desired location while enabling the removal of available genes or/and adding novel genes in vivo.

The Cas9 nuclease acts as a genetic scissor and used to open both the strands of specific DNA sequence for introducing the desired modification through the deployment of any one of the two techniques. These techniques include knock-in mutations which is enabled through the Homology Directed Repair (HDR) and via Non-Homologous End Joining (NHEJ).

The prominent factors favoring the CRISPR & CRISPR-Associated (Cas) genes market growth include technological advancement in gene editing platform and launch of various anti-CRISPR proteins that are expected to improve the overall accuracy of CRISPR technique. SpCas9-HF and eSpCas9 are two novel versions of Cas9 protein that have been designed in laboratory for minimizing the editing activity which is off the target without any use of sgRNAs.

According to the American Association for the Advancement of Science (AAAS) February 2020 release, the researchers have integrated two techniques viz. T cell therapy, which exploits the sentry of the body's immune system for destroying tumors and CRISPR, which is used for editing of DNA. The researchers have found the advanced CRISPR gene editing tool to be very safe when used on three patients suffering from cancer.

According to the Stat News February 2019 publication, China's Science Ministry along with two other government institutions in the country are expected to have funded a study referred to as "CRISPR babies". This study has resulted in the birth of two genetically altered twin girls in November 2018 in China. Therefore, the biological researchers have successfully achieved a key technique to start pregnancy among humans through the deployment of CRISPR Cas9 gene editing tool on human embryos.

Companies such as Addgene, AstraZeneca, Caribou Biosciences, Inc., Cellectis, Cibus, CRISPR Therapeutics, Danaher Corporation, Editas Medicine, Inc., Egenesis, F. Hoffmann-La Roche Ltd., Genscrip, Horizon Discovery Group Plc, Lonza, Mammoth Biosciences, Merck KGaA, New England BioLabs, Synthego, and Takara Bio, Inc. are some of the key players operating in the clustered regularly interspaced short palindromic repeats (CRISPR) & CRISPR-associated (Cas) genes market.

Players in the market are focusing on adopting CRISPR & Cas gene editing technology for engineering the blood stem cells and immune cells as a key tool being deployed for enabling drug discovery while creating highly targeted anticancer drugs. Additionally, in May 2020, the U.S. Food and Drug Administration (FDA) has approved the CRISPR-based diagnostic kit for testing of the SARS-CoV-2 COVID-19 coronavirus in laboratory. According to the Nature Journal May 2020 publication, the U.S. has already increased the COVID-19 testing while averaging about 250,000 COVID-19 test per day. The rapid FDA approval to the test kits is expected to boost testing, reducing backlogs.

Polaris Market Research has segmented the CRISPR & Cas Genes market report on the basis of product & service, application, end-use, and region

CRISPR & Cas Genes Product & Service Outlook (Revenue - USD Million, 2016 - 2027)

By Product

Kits & Enzymes

Vector-based Cas

DNA-free Cas

Libraries

Design Tool

Antibodies

Others

By Service

Cell Line Engineering

gRNA Design

Microbial Gene Editing

DNA Synthesis

CRISPR & Cas Genes Application Outlook (Revenue - USD Million, 2016 - 2027)

Biomedical

Genome Engineering

Disease Model Studies

Functional Genomics

Epigenetics

Others

Agricultural

CRISPR & Cas Genes End-use Outlook (Revenue - USD Million, 2016 - 2027)

Biotechnology & Pharmaceutical Companies

Academics & Government Research Institutes

Contract Research Organizations (CROs)

CRISPR & Cas Genes Regional Outlook (Revenue - USD Million, 2016 - 2027)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Central & South America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. CRISPR and Cas Genes Market Insights

  • 4.1. CRISPR and Cas Genes - Industry snapshot
  • 4.2. CRISPR and Cas Genes Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Innovations in CRISPR technologies
      • 4.2.1.2. Applicability in varied areas
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Low operational efficiency
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. CRISPR and Cas Genes Market Industry trends

5. CRISPR and Cas Genes Market Assessment by Product & Service

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
  • 5.3. Product
    • 5.3.1. Global CRISPR and Cas Genes Market, by Product, by Region, 2016 - 2027 (USD Million)
    • 5.3.2. Kits & Enzymes
      • 5.3.2.1. Kits & Enzymes, by Region, 2016 - 2027 (USD Million)
      • 5.3.2.1.1. Vector-based Cas
      • 5.3.2.1.1.1. Vector-based Cas, by Region, 2016 - 2027 (USD Million)
      • 5.3.2.1.2. DNA-free Cas
      • 5.3.2.1.2.1. DNA-free Cas, by Region, 2016 - 2027 (USD Million)
    • 5.3.3. Libraries
      • 5.3.3.1. Libraries, by Region, 2016 - 2027 (USD Million)
    • 5.3.4. Design Tool
      • 5.3.4.1. Design Tool, by Region, 2016 - 2027 (USD Million)
    • 5.3.5. Antibodies
      • 5.3.5.1. Antibodies, by Region, 2016 - 2027 (USD Million)
    • 5.3.6. Others
      • 5.3.6.1. Others, by Region, 2016 - 2027 (USD Million)
  • 5.4. Service
    • 5.4.1. Global CRISPR and Cas Genes Market, by Service, by Region, 2016 - 2027 (USD Million)
    • 5.4.2. Cell Line Engineering
      • 5.4.2.1. Cell Line Engineering, by Region, 2016 - 2027 (USD Million)
    • 5.4.3. gRNA Design
      • 5.4.3.1. gRNA Design, by Region, 2016 - 2027 (USD Million)
    • 5.4.4. Microbial Gene Editing
      • 5.4.4.1. Microbial Gene Editing, by Region, 2016 - 2027 (USD Million)
    • 5.4.5. DNA Synthesis
      • 5.4.5.1. DNA Synthesis, by Region, 2016 - 2027 (USD Million)

6. Global CRISPR and Cas Genes Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • 6.3. Biomedical
    • 6.3.1. Global CRISPR and Cas Genes Market, by Biomedical, By Region, 2016 - 2027 (USD Million)
  • 6.4. Agricultural
    • 6.4.1. Global CRISPR and Cas Genes Market, by Agricultural, by Region, 2016 - 2027 (USD Million)

7. CRISPR and Cas Genes Market Assessment by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global CRISPR and Cas Genes Market, By End-Use, 2016 - 2027 (USD Million)
  • 7.3. Biotechnology & Pharmaceutical Companies
    • 7.3.1. Global CRISPR and Cas Genes Market, by Biotechnology & Pharmaceutical Companies, by Region, 2016 - 2027 (USD Million)
  • 7.4. Academics & Government Research Institutes
    • 7.4.1. Global CRISPR and Cas Genes Market, by Academics & Government Research Institutes, by Region, 2016 - 2027 (USD Million)
  • 7.5. Contract Research Organizations (CROs)
    • 7.5.1. Global CRISPR and Cas Genes Market, by Contract Research Organizations (CROs), by Region, 2016 - 2027 (USD Million)

8. CRISPR and Cas Genes Market Assessment by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. CRISPR and Cas Genes Market Assessment, By Geography, 2016 - 2027 (USD Million)
  • 8.3. CRISPR and Cas Genes Market - North America
    • 8.3.1. North America: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
    • 8.3.2. North America: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
    • 8.3.3. North America: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.3.4. CRISPR and Cas Genes Market - U.S.
      • 8.3.4.1. U.S.: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.3.4.2. U.S.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.3.4.3. U.S.: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.3.5. CRISPR and Cas Genes Market - Canada
      • 8.3.5.1. Canada: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.3.5.2. Canada.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.3.5.3. Canada: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • 8.4. CRISPR and Cas Genes Market - Europe
    • 8.4.1. Europe: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
    • 8.4.2. Europe.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
    • 8.4.3. Europe: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.4.4. CRISPR and Cas Genes Market - UK
      • 8.4.4.1. UK: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.4.4.2. UK.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.4.4.3. UK: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.4.5. CRISPR and Cas Genes Market - France
      • 8.4.5.1. France: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.4.5.2. France.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.4.5.3. France: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.4.6. CRISPR and Cas Genes Market - Germany
      • 8.4.6.1. Germany: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.4.6.2. Germany.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.4.6.3. Germany: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.4.7. CRISPR and Cas Genes Market - Italy
      • 8.4.7.1. Italy: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.4.7.2. Italy.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.4.7.3. Italy: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.4.8. CRISPR and Cas Genes Market - Spain
      • 8.4.8.1. Spain: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.4.8.2. Spain.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.4.8.3. Spain: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.4.9. CRISPR and Cas Genes Market - Netherlands
      • 8.4.9.1. Netherlands: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.4.9.2. Netherlands.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.4.9.3. Netherlands: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.4.10. CRISPR and Cas Genes Market - Austria
      • 8.4.10.1. Austria: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.4.10.2. Austria.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.4.10.3. Austria: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • 8.5. CRISPR and Cas Genes Market - Asia-Pacific
    • 8.5.1. Asia Pacific: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
    • 8.5.2. Asia Pacific.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
    • 8.5.3. Asia Pacific: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.5.4. CRISPR and Cas Genes Market - China
      • 8.5.4.1. China: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.5.4.2. China.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.5.4.3. China: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.5.5. CRISPR and Cas Genes Market - India
      • 8.5.5.1. India: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.5.5.2. India.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.5.5.3. India: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.5.6. CRISPR and Cas Genes Market - Malaysia
      • 8.5.6.1. Malaysia: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.5.6.2. Malaysia.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.5.6.3. Malaysia: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.5.7. CRISPR and Cas Genes Market - Japan
      • 8.5.7.1. Japan: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.5.7.2. Japan.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.5.7.3. Japan: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.5.8. CRISPR and Cas Genes Market - Indonesia
      • 8.5.8.1. Indonesia: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.5.8.2. Indonesia.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.5.8.3. Indonesia: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.5.9. CRISPR and Cas Genes Market - South Korea
      • 8.5.9.1. South Korea: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.5.9.2. South Korea.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.5.9.3. South Korea: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • 8.6. CRISPR and Cas Genes Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
    • 8.6.2. Middle East & Africa.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
    • 8.6.3. Middle East & Africa: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.6.4. CRISPR and Cas Genes Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.6.4.2. Saudi Arabia.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.6.4.3. Saudi Arabia: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.6.5. CRISPR and Cas Genes Market - UAE
      • 8.6.5.1. UAE: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.6.5.2. UAE.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.6.5.3. UAE: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.6.6. CRISPR and Cas Genes Market - Israel
      • 8.6.6.1. Israel: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.6.6.2. Israel.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.6.6.3. Israel: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.6.7. CRISPR and Cas Genes Market - South Africa
      • 8.6.7.1. South Africa: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.6.7.2. South Africa.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.6.7.3. South Africa: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • 8.7. CRISPR and Cas Genes Market - Latin America
    • 8.7.1. Latin America: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
    • 8.7.2. Latin America.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
    • 8.7.3. Latin America: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.7.4. CRISPR and Cas Genes Market - Mexico
      • 8.7.4.1. Mexico: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.7.4.2. Mexico.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.7.4.3. Mexico: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.7.5. CRISPR and Cas Genes Market - Brazil
      • 8.7.5.1. Brazil: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.7.5.2. Brazil.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.7.5.3. Brazil: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
    • 8.7.6. CRISPR and Cas Genes Market - Argentina
      • 8.7.6.1. Argentina: CRISPR and Cas Genes Market, By Product & Service, 2016 - 2027 (USD Million)
      • 8.7.6.2. Argentina.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
      • 8.7.6.3. Argentina: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansions
    • 9.1.2. Acquisitions
  • 9.2. Product Launch
  • 9.3. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Addgene
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product/Services Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AstraZeneca
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product/Services Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Caribou Biosciences, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product/Services Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Cellectis
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product/Services Benchmarking
    • 10.4.4. Recent Development
  • 10.5. CRISPR Therapeutics
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product/Services Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Danaher Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product/Services Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Editas Medicine, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product/Services Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Horizon Discovery Group Plc
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product/Services Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Mammoth Biosciences
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product/Services Benchmarking
    • 10.9.4. Recent Development
  • 10.10. New England BioLabs
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product/Services Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 2 Global CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 3 Global CRISPR and Cas Genes Market, By End-Use, 2016 - 2027 (USD Million)
  • Table 4 CRISPR and Cas Genes Market Assessment, By Geography, 2016 - 2027 (USD Million)
  • Table 5 North America: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 6 North America: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 7 North America: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 8 U.S.: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 9 U.S.: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 10 U.S.: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 11 Canada: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 12 Canada: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 13 Canada: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 14 Europe: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 15 Europe: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 16 Europe: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 17 UK: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 18 UK: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 19 UK: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 20 France: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 21 France: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 22 France: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 23 Germany: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 24 Germany: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 25 Germany: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 26 Italy: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 27 Italy: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 28 Italy: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 29 Spain: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 30 Spain: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 31 Spain: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 32 Netherlands: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 33 Netherlands: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 34 Netherlands: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 35 Austria: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 36 Austria: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 37 Austria: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 38 Asia Pacific: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 39 Asia Pacific: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 40 Asia Pacific: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 41 China: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 42 China: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 43 China: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 44 India: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 45 India: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 46 India: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 47 Malaysia: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 48 Malaysia: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 49 Malaysia: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 50 Japan: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 51 Japan: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 52 Japan: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 53 Indonesia: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 54 Indonesia: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 55 Indonesia: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 56 South Korea: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 57 South Korea: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 58 South Korea: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 59 Middle East & Africa: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 60 Middle East & Africa: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 61 Middle East & Africa: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 62 Saudi Arabia: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 63 Saudi Arabia: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 64 Saudi Arabia: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 65 UAE: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 66 UAE: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 67 UAE: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 68 Israel: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 69 Israel: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 70 Israel: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 71 South Africa: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 72 South Africa: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 73 South Africa: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 74 Latin America: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 75 Latin America: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 76 Latin America: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 77 Mexico: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 78 Mexico: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 79 Mexico: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 80 Brazil: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 81 Brazil: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 82 Brazil: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)
  • Table 83 Argentina: CRISPR and Cas Genes Market, By Product and Services, 2016 - 2027 (USD Million)
  • Table 84 Argentina: CRISPR and Cas Genes Market, By Application, 2016 - 2027 (USD Million)
  • Table 85 Argentina: CRISPR and Cas Genes Market, By End Use, 2016 - 2027 (USD Million)

List of Figures

Figure 1. Market Highlights (2019, Revenue)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top Down & Bottom Up Approach

Figure 4. Market by Geography

Figure 6. Porter's Five Forces

Figure 7. Market by Product and Services

Figure 8. Global CRISPR and Cas Genes Market, By Product and Services, 2019 & 2027 (USD Million)

Figure 9. Market by Application

Figure 10. Global CRISPR and Cas Genes Market, By Application, 2019 & 2027 (USD Million)

Figure 11. Market by End-Use

Figure 12. Global CRISPR and Cas Genes Market, By End-Use, 2019 & 2027 (USD Million)

Figure 13. CRISPR and Cas Genes Market Assessment, By Geography, 2016 - 2027 (USD Million)

Figure 14. Strategic Analysis - CRISPR and Cas Genes Market